103 related articles for article (PubMed ID: 2141287)
1. Human acid beta-glucosidase: use of sphingosyl and N-alkyl-glucosylamine inhibitors to investigate the properties of the active site.
Greenberg P; Merrill AH; Liotta DC; Grabowski GA
Biochim Biophys Acta; 1990 May; 1039(1):12-20. PubMed ID: 2141287
[TBL] [Abstract][Full Text] [Related]
2. Human acid beta-glucosidase: use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sites.
Osiecki-Newman K; Fabbro D; Legler G; Desnick RJ; Grabowski GA
Biochim Biophys Acta; 1987 Sep; 915(1):87-100. PubMed ID: 2956992
[TBL] [Abstract][Full Text] [Related]
3. Analyses of catalytic activity and inhibitor binding of human acid beta-glucosidase by site-directed mutagenesis. Identification of residues critical to catalysis and evidence for causality of two Ashkenazi Jewish Gaucher disease type 1 mutations.
Grace ME; Graves PN; Smith FI; Grabowski GA
J Biol Chem; 1990 Apr; 265(12):6827-35. PubMed ID: 2324100
[TBL] [Abstract][Full Text] [Related]
4. Isolation of a cytosolic beta-glucosidase from calf liver and characterization of its active site with alkyl glucosides and basic glycosyl derivatives.
Legler G; Bieberich E
Arch Biochem Biophys; 1988 Jan; 260(1):427-36. PubMed ID: 2963589
[TBL] [Abstract][Full Text] [Related]
5. Study of beta-glucosidase from Helix pomatia by active site-directed inhibitors.
Donsimoni R; Legler G; Bourbouze R; Lalegerie P
Enzyme; 1988; 39(2):78-89. PubMed ID: 2969330
[TBL] [Abstract][Full Text] [Related]
6. Human acid beta-glucosidase: inhibition studies using glucose analogues and pH variation to characterize the normal and Gaucher disease glycon binding sites.
Osiecki-Newman K; Legler G; Grace M; Dinur T; Gatt S; Desnick RJ; Grabowski GA
Enzyme; 1988; 40(4):173-88. PubMed ID: 3234317
[TBL] [Abstract][Full Text] [Related]
7. Glucosylceramidase from calf spleen. Characterization of its active site with 4-n-alkylumbelliferyl beta-glucosides and N-alkyl derivatives of 1-deoxynojirimycin.
Legler G; Liedtke H
Biol Chem Hoppe Seyler; 1985 Dec; 366(12):1113-22. PubMed ID: 2936366
[TBL] [Abstract][Full Text] [Related]
8. Specificity of human glucosylceramide beta-glucosidase towards synthetic glucosylsphingolipids inserted into liposomes. Kinetic studies in a detergent-free assay system.
Sarmientos F; Schwarzmann G; Sandhoff K
Eur J Biochem; 1986 Nov; 160(3):527-35. PubMed ID: 3780720
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of N-alkyl-beta-D-glucosylamines and their antimicrobial activity against Fusarium proliferatum, Salmonella typhimurium, and Listeria innocua.
Muhizi T; Grelier S; Coma V
J Agric Food Chem; 2009 Dec; 57(23):11092-9. PubMed ID: 19908897
[TBL] [Abstract][Full Text] [Related]
10. Human lysosomal beta-glucosidase: kinetic characterization of the catalytic, aglycon, and hydrophobic binding sites.
Grabowski GA; Gatt S; Kruse J; Desnick RJ
Arch Biochem Biophys; 1984 May; 231(1):144-57. PubMed ID: 6426391
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of beta-glucosidase by imidazoles.
Li YK; Byers LD
Biochim Biophys Acta; 1989 Dec; 999(3):227-32. PubMed ID: 2532549
[TBL] [Abstract][Full Text] [Related]
12. Kinetic analysis of the interaction of alkyl glycosides with two human beta-glucosidases.
Gopalan V; Daniels LB; Glew RH; Claeyssens M
Biochem J; 1989 Sep; 262(2):541-8. PubMed ID: 2508630
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the catalytic mechanism of a plant beta-D-glucan glucohydrolase through structural biology using inhibitors and substrate analogues.
Hrmova M; Fincher GB
Carbohydr Res; 2007 Sep; 342(12-13):1613-23. PubMed ID: 17548065
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of beta-glucosidases from almonds by cationic and neutral beta-glucosyl derivatives.
Legler G
Biochim Biophys Acta; 1978 May; 524(1):94-101. PubMed ID: 418817
[TBL] [Abstract][Full Text] [Related]
15. Human acid beta-glucosidase. Use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes.
Grabowski GA; Osiecki-Newman K; Dinur T; Fabbro D; Legler G; Gatt S; Desnick RJ
J Biol Chem; 1986 Jun; 261(18):8263-9. PubMed ID: 3087971
[TBL] [Abstract][Full Text] [Related]
16. N-hexyl-O-glucosyl sphingosine, an inhibitor of glucosyl ceramide -glucosidase.
Erickson JS; Radin NS
J Lipid Res; 1973 Mar; 14(2):133-7. PubMed ID: 4698260
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of yeast exoglucanases by glucosidase inhibitors.
Ridruejo JC; Muñoz MD; Andaluz E; Larriba G
Biochim Biophys Acta; 1989 Dec; 993(2-3):179-85. PubMed ID: 2532041
[TBL] [Abstract][Full Text] [Related]
18. Chemical modification of the glucosidase inhibitor 1-deoxynojirimycin. Structure-activity relationships.
Tan A; van den Broek L; van Boeckel S; Ploegh H; Bolscher J
J Biol Chem; 1991 Aug; 266(22):14504-10. PubMed ID: 1650361
[TBL] [Abstract][Full Text] [Related]
19. Human acid beta-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site.
Dinur T; Osiecki KM; Legler G; Gatt S; Desnick RJ; Grabowski GA
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1660-4. PubMed ID: 3456607
[TBL] [Abstract][Full Text] [Related]
20. Kinetic study of the inhibition of the honeybee haemolymph apha-glucosidase in vitro by BAYe 4609, BAYg 5421 and BAYn 5595.
Bounias M
Biochem Pharmacol; 1982 Sep; 31(17):2769-75. PubMed ID: 6215920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
